Stay updated on Pemigatinib Dose-Escalation Clinical Trial
Sign up to get notified when there's something new on the Pemigatinib Dose-Escalation Clinical Trial page.

Latest updates to the Pemigatinib Dose-Escalation Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now indicates that recruitment has ended, and additional user-oriented sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' have been added, while the 'Intervention/Treatment' header formatting was adjusted and the revision tag updated.SummaryDifference0.2%

- Check21 days agoChange DetectedRevision tag updated to v3.5.5, signaling a minor maintenance update to the page rather than substantive changes to study content.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a small editorial/metadata update. This change does not modify the study content or outcomes.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page’s footer site release marker was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a maintenance/site version change rather than study information.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision updated to v3.5.2; revision v3.5.0 was removed.SummaryDifference0.0%

- Check100 days agoChange DetectedRevision updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Pemigatinib Dose-Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pemigatinib Dose-Escalation Clinical Trial page.